Literature DB >> 20192624

Atypical spine involvement of Erdheim-Chester disease in an elderly male.

Andrew M Allmendinger1, Alan V Krauthamer, Vadim Spektor, Mohamed S Aziz, Bruce Zablow.   

Abstract

Erdheim-Chester disease is a rare form of non-Langerhans histiocytosis presenting in the 5th through 7th decades of life. Osseous manifestations include symmetrical sclerosis of the long bones and, rarely, the spine. Central nervous system disease commonly affects the white matter tracts as well as the orbits, but epidural disease is rare. To the best of the authors' knowledge, simultaneous epidural and skeletal spine disease has not been reported. The MR imaging characteristics of skeletal spine disease have also not been reported. The authors describe the case of an 87-year-old man with both epidural and skeletal spine disease. The clinical characteristics, imaging manifestations, and the histological features are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20192624     DOI: 10.3171/2009.10.SPINE09316

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  4 in total

1.  Erdheim-Chester disease associated with intramedullary spinal cord lesion.

Authors:  T Takeuchi; M Sato; T Sonomura; T Itakura
Journal:  Br J Radiol       Date:  2012-03       Impact factor: 3.039

2.  Erdheim-Chester disease of the central nervous system: new manifestations of a rare disease.

Authors:  P Sedrak; L Ketonen; P Hou; N Guha-Thakurta; M D Williams; R Kurzrock; J M Debnam
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-29       Impact factor: 3.825

Review 3.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

4.  Atypical skeletal involvement in patients with Erdheim-Chester disease: CT imaging findings.

Authors:  Zaizhu Zhang; Wei Yu; Wenmin Guan; Qiang Lin; Ali Guermazi
Journal:  Orphanet J Rare Dis       Date:  2022-02-03       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.